Free Trial
NASDAQ:INVO

INVO Bioscience (INVO) Stock Price, News & Analysis

INVO Bioscience logo
$0.79 +0.01 (+1.69%)
As of 07/14/2025

About INVO Bioscience Stock (NASDAQ:INVO)

Key Stats

Today's Range
$0.74
$0.80
50-Day Range
$0.78
$2.18
52-Week Range
$0.63
$3.50
Volume
155,603 shs
Average Volume
1.59 million shs
Market Capitalization
$3.00 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive INVO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for INVO Bioscience and its competitors with MarketBeat's FREE daily newsletter.

INVO Stock News Headlines

This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in crypto. Now it’s back, and the smart money is already positioning. A free training reveals the step-by-step strategy and altcoin picks designed to help you capitalize on the next wave.
NAYA Biosciences Inc trading halted, news pending
NAYA Biosciences to effect 1-for-12 reverse split
See More Headlines

INVO Stock Analysis - Frequently Asked Questions

INVO Bioscience's stock was trading at $0.81 at the start of the year. Since then, INVO stock has decreased by 2.6% and is now trading at $0.7889.

INVO Bioscience, Inc. (NASDAQ:INVO) issued its quarterly earnings data on Monday, November, 15th. The company reported ($4.80) EPS for the quarter, missing the consensus estimate of ($4.00) by $0.80. The business had revenue of $0.22 million for the quarter, compared to analysts' expectations of $0.25 million.

Shares of INVO Bioscience reverse split on the morning of Thursday, July 27th 2023.The 1-20 reverse split was announced on Thursday, July 27th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 27th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of INVO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that INVO Bioscience investors own include NVIDIA (NVDA), NIO (NIO), Tesla (TSLA), Meta Platforms (META), Broadcom (AVGO) and Bilibili (BILI).

Company Calendar

Last Earnings
11/15/2021
Today
7/15/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:INVO
CIK
1417926
Fax
N/A
Employees
25
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.03 million
Net Margins
-122.79%
Pretax Margin
-122.32%
Return on Equity
N/A
Return on Assets
-36.94%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.30
Quick Ratio
0.27

Sales & Book Value

Annual Sales
$5.77 million
Price / Sales
0.52
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.38

Miscellaneous

Outstanding Shares
3,809,000
Free Float
3,769,000
Market Cap
$3.00 million
Optionable
No Data
Beta
1.43
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

This page (NASDAQ:INVO) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners